This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Krystal Biotech, Inc.
Q42023
2/26/2024
Kate Romano
Chief Accounting Officer
thank you for holding we look forward to talking with you soon please hold the line and we'll be right back with you so
Automated System
Hold Message
Thanks for holding. We appreciate your time and patience. Please stay on the line, and we'll be back in just a moment.
Conference Operator
Operator
Thank you for standing by and welcome to the Crystal Biotech fourth quarter and full year 2023 earnings conference call. At this time, all participants are on a listen-only mode. After the speaker's presentations, there will be a question and answer session. As a reminder, today's conference is being recorded. I would now like to hand the conference over to your host, Meg Dodge, Head of Investor Relations and Corporate Communications. Please begin.
You're reading a preview of the KRYS Q4 2023 earnings call.
Free account.
Disclaimer